Solid Biosciences Inc. Net Income Loss

Quick Answer

Solid Biosciences Inc. reported Net Income Loss of -$117.22 million for the year ending 2019.

  • Solid Biosciences Inc. showed a decrease of -56.7% in Net Income Loss from 2018 to 2019.
  • This data is from Solid Biosciences Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2020.
  • XBRL data for this metric is available from 2016 to 2019 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2016 to 2019), Solid Biosciences Inc.'s Net Income Loss has declined by 444.2%.
  • Historical annual values: Fiscal year 2019: -$117.22 million | Fiscal year 2018: -$74.80 million | Fiscal year 2017: -$52.12 million | Fiscal year 2016: -$21.54 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: